Children's Loratadine Oral Solution

Manufacturer
Lannett Company, Inc.
Effective date
2025-06-19
Label type
HUMAN OTC DRUG LABEL
Version
16
Source
full-release
Hydrated at
2026-06-01 01:03:41

Label at a glance#

ProductLoratadine
Active ingredientLORATADINE
Label structure18 sections

Indications and uses

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat

Dosage and administration

use only with enclosed dosing cup mL = milliliter  adults and children 6 years and over 10 mL daily; do not take more than 10 mL in 24 hours  children 2 to under 6 years of age 5 mL daily; do not take more than 5 mL in 24 hours  children under 2 years of age  ask a doctor  consumers with liver or kidney disease  ask a doctor

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Loratadine 5 mg (in each 5 mL)

OTC - PURPOSE SECTION

Purpose: Antihistamine

Uses

INDICATIONS & USAGE SECTION

temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:

  • runny nose
  • itchy, watery eyes
  • sneezing
  • itching of the nose or throat

Warnings

WARNINGS SECTION

Do not use if you have ever had allergic reaction to this product or any of its ingredients.

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.

OTC - WHEN USING SECTION

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

OTC - STOP USE SECTION

Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • use only with enclosed dosing cup
  • mL = milliliter
 adults and children 6 years and over
10 mL daily; do not take more than 10 mL in 24 hours
 children 2 to under 6 years of age
5 mL daily; do not take more than 5 mL in 24 hours
 children under 2 years of age
 ask a doctor
 consumers with liver or kidney disease
 ask a doctor

Other information

SPL UNCLASSIFIED SECTION

  • Each 5 mL contains: sodium 1 mg
  • do not use if seal imprinted with "SEALED FOR
    YOUR PROTECTION" around bottle is not intact
  • Store between 20° to 25°C (68° to 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

butylated hydroxylanisole, citric acid, glycerin, grape flavor, propylene glycol, purified water, sodium benzoate, sucralose.

Questions or comments?

OTC - QUESTIONS SECTION

1-844-834-0530

Distributed by:
Lannett Company, Inc.
Philadelphia, PA 19136

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient: Loratadine 5 mg (in each 5 mL(teaspoonful(tsp)))

OTC - PURPOSE SECTION

Purpose: Antihistamine

Uses

INDICATIONS & USAGE SECTION

  • relieves itching due to hives (urticaria). This product will not prevent hives or an allergic skin reaction from occurring.

Warnings

WARNINGS SECTION

Severe Allergy Warning: Get emergency help immediately if you have hives along with any of the following symptoms:

  • trouble swallowing
  • dizziness or loss of consciousness
  • swelling of tongue
  • swelling in or around mouth
  • trouble speaking
  • drooling
  • wheezing or problems breathing

These symptoms may be signs of anaphylactic shock. This condition can be life threatening if not treated by a health professional immediately. Symptoms of anaphylactic shock may occur when hives first appear or up to a few hours later.

Not a Substitute for Epinephrine. If your doctor has prescribed an epinephrine injector for “anaphylaxis” or severe allergy symptoms that could occur with your hives, never use this product as a substitute for the epinephrine injector. If you have been prescribed an epinephrine injector, you should carry it with you at all times.

Do not use

OTC - DO NOT USE SECTION

- to prevent hives from any known cause such as:

  • foods
  • insects stings
  • medicines
  • latex or rubber gloves

because this product will not stop hives from occurring. Avoiding the cause of your hives is the only way to prevent them. Hives can sometimes be serious. If you do not know the cause of your hives, see your doctor for a medical exam. Your doctor may be able to help you find a cause.

- if you have ever had an allergic reaction to this product (loratadine) or any of its ingredients

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have

  • liver or kidney disease. Your doctor should determine if you need a different dose.
  • hives that are an unusual color, look bruised or blistered
  • hives that do not itch

OTC - WHEN USING SECTION

When using this product do not take more than directed. Taking more than directed may cause drowsiness.

OTC - STOP USE SECTION

Stop use and ask a doctor if

  • an allergic reaction to this product occurs. Get medical help right away
  • symptoms don’t improve after 3 days of treatment
  • the hives have lasted more than 6 weeks

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

 adults and children 6 years and over
 2 teaspoonfuls (tsp) daily; do not take more than 2 teaspoonfuls (tsp) in 24 hours
 children under 6 years of age
 ask a doctor
 consumers with liver or kidney disease
 ask a doctor
Other information
  • Safety sealed. Do not use if imprinted seal around cap is broken or missing
  • Store between 20° to 25°C (68° to 77°F)

Inactive ingredients

INACTIVE INGREDIENT SECTION

Butylated hydroxyanisole, citric acid, glycerin, grape flavor, propylene glycol, purified water, sodium benzoate, sucralose.

Questions

OTC - QUESTIONS SECTION

1-844-834-0530

Manufactured by:
Silarx Pharmaceuticals, Inc.
1033 Stoneleigh Ave
Carmel, NY 10512 

Patient Leaflet

SPL PATIENT PACKAGE INSERT SECTION

Once Daily / Non-Drowsy*
Loratadine Oral Solution
Hives Relief
5 mg per 5 mL
Antihistamine

What you should know about:
Non- Drowsy*
Loratadine Oral Solution – Hives Relief
Original Prescription Strength – 24 Hour Product

Relief of Itching Due to Hives
(Please read all of this information before taking Loratadine Oral Solution – Hives Relief Product. Save this leaflet for future reference.)

What is Loratadine Oral Solution - Hives Relief product?

Loratadine Oral Solution - Hives Relief product contain loratadine, a non-drowsy *antihistamine.

 Loratadine Oral Solution – Hives Relief
Original prescription strength medicine to relieve itching due to hives.

What are hives and what do they look like?
Hives are itchy raised red or pink bumps, blotches or streaky areas of various sizes on the surface of the skin. They can come and go.

Do not use this product if your hives look bruised, have an unusual color, or look blistered. These may be signs of a more serious problem. If you have these signs, ask a Doctor before taking Loratadine Oral Solution -Hives Relief product.

What can cause hives?
Many things, including food, drugs (medicines), insect stings, stress, exercise or temperature can cause hives. A doctor may be able to help you find the cause of your hives. When you know the cause, avoid it.

Do not use this product to prevent hives or allergic skin reactions known to be caused by food, insect stings, medicines, latex or rubber gloves, or any other causes. Many medicines can cause hives.

How long do hives last?
Hives can last from a few hours to a few weeks, and often come and go. See a doctor if your hives have lasted more than 6 weeks.

Are hives very serious?
Hives are very common and they are usually not serious. But in rare cases, they can be the first sign of a life threatening allergic reaction called anaphylaxis. A sign that you have this serious reaction would be that you have hives along with any of the following symptoms:

  • Dizziness or feeling faint
  • Trouble swallowing
  • Wheezing or problems breathing
  • Trouble speaking
  • Hives or swelling in or around the mouth
  • Drooling

Hives AND any of these symptoms means call 911 or Get Immediate Medical Help

Can I use Loratadine Oral Solution -Hives Relief product instead of an epinephrine injection for my allergic reaction?

Never use Loratadine Oral Solution – Hives Relief product as a substitute for epinephrine.
If your doctor has prescribed an epinephrine injector for your severe allergic reactions, your doctor is concerned that your hives might lead to a severe allergic reaction (anaphylaxis) or to asthma-like symptoms that could occur with your hives. Loratadine Oral Solution – Hives Relief product is not a substitute for epinephrine. If you have been prescribed an epinephrine injector, carry it with you at all times.

Who can take Loratadine Oral Solution – Hives Relief Product?
People who have hives (urticaria) and are 6 years of age or older can take Loratadine Oral Solution – Hives Relief product. (See label Directions for proper dose.)

Who should not take Loratadine Oral Solution – Hives Relief Product?

  • People who have ever had an allergic reaction to these products or any of their ingredients.
  • People who are taking any other products containing loratadine
  • People with liver or kidney disease unless directed by a doctor
  • Children under the age of 6 years.

What if I know the cause of my hives and I want to take Loratadine Oral Solution – Hives Relief Product to prevent the hives from occurring?
Loratadine Oral Solution – Hives Relief product should never be used to prevent hives or allergic skin reactions from any known cause. Such causes can include but are not limited to:

  • Food
  • Insect Stings
  • Medicines
  • Latex or rubber gloves.

If you have ever had an allergic reaction to any of these causes, you should see a doctor.

When should you contact a doctor?
Contact a doctor before taking Loratadine Oral Solution – Hives Relief
product if you have:

  • Hives that have an unusual color or that look bruised or blistered
  • Hives that have lasted longer than 6 weeks

If you are pregnant or breast feeding, you should ask a doctor or health professional before use.

Contact a doctor while taking Loratadine Oral Solution – Hives Relief Product if you (or your child) have:

  • A rash or itching that does not get better after taking Loratadine Oral Solution – Hives Relief product for 3 days
  • Hives that keep coming back.

How long can Loratadine Oral Solution – Hives Relief product be taken to relieve the itching?
Loratadine Oral Solution – Hives Relief product can be taken during the entire time that you have itching due to hives (see Directions). Don’t forget, if the hives last longer than 6 weeks, contact your doctor.

How should Loratadine Oral Solution – Hives Relief product be taken?

  • Adults and children 6 years and older should take 2 teaspoonfuls of Loratadine Oral Solution (10 mg) daily.
  • Do not take more than one dose in 24 hour period.
  • If you have liver or kidney disease, ask a doctor.

What else can I do to make the itching and rash feel better?
Wear loose clothing to help reduce irritation. Keeping the temperature cool can help with the itching.

Other important information:

  • Allergy Alert: Do not use if you are allergic to loratadine, any of its ingredients, or other antihistamines.
  • If you have been prescribed an epinephrine injector, you should carry it with you at all times.
  • Keep out of reach of children.
  • In case of an overdose, get medical help or contact a Poison Control Center right away.

* When taken as directed. See drug facts panel on carton.

Silarx Pharmaceuticals, Inc.

1033 Stoneleigh Ave.
Carmel, NY 10512

10-1108

Rev. 11/17

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

SPL carton
SPL carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL


Hives Carton
Hives Carton

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
692783loratadine 5 MG in 5 mL Oral SolutionPSN16
692783loratadine 1 MG/ML Oral SolutionSCD16
692783loratadine 5 MG per 5 ML Oral SolutionSY16

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
3c386306-c48a-413e-bb69-70cb268496f3Product name120210727
ce6d5c06-3ae0-18a6-d5b3-8cd3cc0f8906Product name720210625
f52be47f-7aa7-46c0-b1fa-50c18dd50206Product name120201029
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
54838-554-40Loratadine120 mL in 1 CARTONSOLUTION12016
54838-558-40Loratadine120 mL in 1 CARTONSOLUTION12016

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
54838-558-40ML - Milliliter54838-55871580501-26ba-4aba-ae44-65e115f9693212012-07-24
54838-554-40ML - Milliliter54838-55488c8c3a2-7784-4881-a65a-b14ce9f1f49112012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
LoratadineACTIVE INGREDIENT7AJO3BO7QN12
LoratadineACTIVE MOIETY7AJO3BO7QN12
anhydrous citric acidINACTIVE INGREDIENTXF417D3PSL12
butylated hydroxyanisoleINACTIVE INGREDIENTREK4960K2U12
glycerinINACTIVE INGREDIENTPDC6A3C0OX12
propylene glycolINACTIVE INGREDIENT6DC9Q167V312
sodium benzoateINACTIVE INGREDIENTOJ245FE5EU12
sucraloseINACTIVE INGREDIENT96K6UQ3ZD412
waterINACTIVE INGREDIENT059QF0KO0R12

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
54838-55854838-558-40
54838-55454838-554-40

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 24 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUSOLUTION / ORAL660 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
sucraloseSUCRALOSE96K6UQ3ZD4SOLUTION / ORAL800 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
butylated hydroxyanisoleBUTYLATED HYDROXYANISOLEREK4960K2USOLUTION / ORAL5 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / ORAL3900 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / ORAL3900 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / ORAL3900 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
sucraloseSUCRALOSE96K6UQ3ZD4SOLUTION / ORAL800 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION / ORAL32400 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION / ORAL32400 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
sucraloseSUCRALOSE96K6UQ3ZD4SOLUTION / ORAL800 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUSOLUTION / ORAL660 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUSOLUTION / ORAL660 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
butylated hydroxyanisoleBUTYLATED HYDROXYANISOLEREK4960K2USOLUTION / ORAL5 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
propylene glycolPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
sucraloseSUCRALOSE96K6UQ3ZD4SOLUTION / ORAL800 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION / ORAL32400 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
anhydrous citric acidANHYDROUS CITRIC ACIDXF417D3PSLSOLUTION / ORAL3900 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
sodium benzoateSODIUM BENZOATEOJ245FE5EUSOLUTION / ORAL660 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
butylated hydroxyanisoleBUTYLATED HYDROXYANISOLEREK4960K2USOLUTION / ORAL5 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
glycerinGLYCERINPDC6A3C0OXSOLUTION / ORAL32400 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
butylated hydroxyanisoleBUTYLATED HYDROXYANISOLEREK4960K2USOLUTION / ORAL5 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A077421-001LORATADINELORATADINE1MG/MLSYRUP / ORAL2006-06-29

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 44 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-10-15 13:18:302026-09A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29c2088c7a36db…
2026-09-14 22:38:342026-08A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-2984e616aacf4f…
2026-08-18 06:07:402026-07A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-2931067a03dcf5…
2025-08-23 18:47 UTC2025-08A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-296a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-2903ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-292680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-295bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-2979d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-291e350fbaab3a…
2024-05-31 18:47 UTC2024-05A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-298072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-295c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-295d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-294b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-2974a2ff9319b5…
2022-03-09 01:35 UTC2022-03A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-2987673890dc5c…
2021-03-12 10:30 UTC2021-03A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-295aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-298869cabd3fbd…
2020-11-12 02:37 UTC2020-11A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29c0c555d07b60…
2019-12-14 00:12 UTC2019-12A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-293f01610625f2…
2019-09-15 20:21 UTC2019-09A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29b00525d2431f…
2019-07-19 19:46 UTC2019-07A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-296a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-291c564ffb4f44…
2023-12-20 04:57 UTC2023-12A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-299b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-293f0d92c62455…
2023-05-13 08:27 UTC2023-05A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-29053a50430f4f…
2023-01-26 05:58 UTC2023-01A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-293bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A077421-001LORATADINE1MG/MLSYRUP / ORAL2006-06-293a93d1ddd44b…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LoratadineLORATADINELannett Company, Inc.069c4e75-1f9f-4ab5-9570-3d93d12c2a232025-06-19WarningsExact identifier
ndc (package): 54838-558-40
ndc (package): 54838-554-40
ndc (product): 54838-558
ndc (product): 54838-554
ndc11 (package): 54838055440
ndc11 (package): 54838055840
spl id: fd40a94c-2173-4b80-a049-ab3c4faf24f4
spl set id: 069c4e75-1f9f-4ab5-9570-3d93d12c2a23

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.